{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:33:20Z","timestamp":1793795600149,"version":"4.6.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project on Medical Education in 2023 by the Medical Education Branch of the Chinese Medical Association","award":["2023B266"],"award-info":[{"award-number":["2023B266"]}],"id":[{"id":"https:\/\/ror.org\/044fynn32","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2024 Teaching Quality and Teaching Reform Project of Wannan Medical College","award":["2024jyxm72"],"award-info":[{"award-number":["2024jyxm72"]}],"id":[{"id":"https:\/\/ror.org\/037ejjy86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04826-0","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:34:45Z","timestamp":1764081285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Addressing the challenges of immunogenicity, heterogeneity and tumorigenicity in the clinical translation of human embryonic stem cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Lishuang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"5391","key":"4826_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"4","key":"4826_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27(4):523\u201331.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4826_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/stem.2450","volume":"35","author":"D Ilic","year":"2017","unstructured":"Ilic D, Ogilvie C. Concise review: human embryonic stem cells-what have we done? What are we doing? Where are we going? Stem Cells. 2017;35(1):17\u201325.","journal-title":"Stem Cells"},{"issue":"1","key":"4826_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68.","journal-title":"Stem Cell Res Ther"},{"issue":"6569","key":"4826_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/380064a0","volume":"380","author":"KH Campbell","year":"1996","unstructured":"Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature. 1996;380(6569):64\u20136.","journal-title":"Nature"},{"issue":"6","key":"4826_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.cell.2013.05.006","volume":"153","author":"M Tachibana","year":"2013","unstructured":"Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228\u201338.","journal-title":"Cell"},{"issue":"1","key":"4826_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s13287-020-01907-0","volume":"11","author":"ZP Zhang","year":"2020","unstructured":"Zhang ZP, Zhang JT, Huang SC, He XY, Deng LX. Double sperm cloning (DSC) is a promising strategy in mammalian genetic engineering and stem cell research. Stem Cell Res Ther. 2020;11(1):388.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4826_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"key":"4826_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4419-7037-4_14","volume":"695","author":"M Nakagawa","year":"2010","unstructured":"Nakagawa M, Yamanaka S. Reprogramming of somatic cells to pluripotency. Adv Exp Med Biol. 2010;695:215\u201324.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"4826_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nprot.2009.231","volume":"5","author":"K Okita","year":"2010","unstructured":"Okita K, Hong H, Takahashi K, Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc. 2010;5(3):418\u201328.","journal-title":"Nat Protoc"},{"issue":"1","key":"4826_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-023-01873-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Behdarvand Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M, et al. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Mol Cancer. 2023;22(1):189.","journal-title":"Mol Cancer"},{"issue":"7","key":"4826_CR12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI80575","volume":"125","author":"E Neofytou","year":"2015","unstructured":"Neofytou E, O\u2019Brien CG, Couture LA, Wu JC. Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest. 2015;125(7):2551\u20137.","journal-title":"J Clin Invest"},{"key":"4826_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2017.00645","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Li W, Fu X, Xu Y. The immunogenicity and immune tolerance of pluripotent stem cell derivatives. Front Immunol. 2017;8:645.","journal-title":"Front Immunol"},{"issue":"23","key":"4826_CR14","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1016\/j.molcel.2022.10.022","volume":"82","author":"S Hu","year":"2022","unstructured":"Hu S, Metcalf E, Mahat DB, Chan L, Sohal N, Chakraborty M, et al. Transcription factor antagonism regulates heterogeneity in embryonic stem cell states. Mol Cell. 2022;82(23):4410-4427.e4412.","journal-title":"Mol Cell"},{"issue":"35","key":"4826_CR15","doi-asserted-by":"publisher","first-page":"12991","DOI":"10.1073\/pnas.0805802105","volume":"105","author":"RJ Swijnenburg","year":"2008","unstructured":"Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A. 2008;105(35):12991\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7350","key":"4826_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212\u20135.","journal-title":"Nature"},{"issue":"10","key":"4826_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41587-019-0227-7","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Agbor-Enoh S, Koch M, Spitzer MH, Gravina A, et al. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans. Nat Biotechnol. 2019;37(10):1137\u201344.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4826_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/gm354","volume":"4","author":"X Fu","year":"2012","unstructured":"Fu X, Xu Y. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med. 2012;4(6):55.","journal-title":"Genome Med"},{"issue":"1575","key":"4826_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1098\/rstb.2011.0030","volume":"366","author":"CJ Taylor","year":"2011","unstructured":"Taylor CJ, Bolton EM, Bradley JA. Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci. 2011;366(1575):2312\u201322.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"4826_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","volume":"4","author":"S Petrus-Reurer","year":"2021","unstructured":"Petrus-Reurer S, Romano M, Howlett S, Jones JL, Lombardi G, Saeb-Parsy K. Immunological considerations and challenges for regenerative cellular therapies. Commun Biol. 2021;4(1):798.","journal-title":"Commun Biol"},{"key":"4826_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662360","volume":"12","author":"C Flahou","year":"2021","unstructured":"Flahou C, Morishima T, Takizawa H, Sugimoto N. Fit-for-all iPSC-derived cell therapies and their evaluation in humanized mice with NK cell immunity. Front Immunol. 2021;12:662360.","journal-title":"Front Immunol"},{"issue":"1","key":"4826_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","volume":"14","author":"Z Rong","year":"2014","unstructured":"Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H, et al. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell. 2014;14(1):121\u201330.","journal-title":"Cell Stem Cell"},{"key":"4826_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.omtm.2020.01.005","volume":"16","author":"G Almeida-Porada","year":"2020","unstructured":"Almeida-Porada G, Atala AJ, Porada CD. Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery. Mol Ther Methods Clin Dev. 2020;16:204\u201324.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4826_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020240","author":"M Jarrige","year":"2021","unstructured":"Jarrige M, Frank E, Herardot E, Martineau S, Darle A, Benabides M, et al. The future of regenerative medicine: cell therapy using pluripotent stem cells and acellular therapies based on extracellular vesicles. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10020240.","journal-title":"Cells"},{"key":"4826_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41232-019-0106-0","volume":"39","author":"M Umekage","year":"2019","unstructured":"Umekage M, Sato Y, Takasu N. Overview: an iPS cell stock at CiRA. Inflamm Regen. 2019;39:17.","journal-title":"Inflamm Regen"},{"issue":"4","key":"4826_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stemcr.2016.08.010","volume":"7","author":"S Sugita","year":"2016","unstructured":"Sugita S, Iwasaki Y, Makabe K, Kamao H, Mandai M, Shiina T, et al. Successful transplantation of retinal pigment epithelial cells from MHC homozygote iPSCs in MHC-matched models. Stem Cell Rep. 2016;7(4):635\u201348.","journal-title":"Stem Cell Rep"},{"key":"4826_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41232-020-00125-8","volume":"40","author":"R Otsuka","year":"2020","unstructured":"Otsuka R, Wada H, Murata T, Seino KI. Immune reaction and regulation in transplantation based on pluripotent stem cell technology. Inflamm Regen. 2020;40:12.","journal-title":"Inflamm Regen"},{"issue":"9502","key":"4826_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(05)67813-0","volume":"366","author":"CJ Taylor","year":"2005","unstructured":"Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet. 2005;366(9502):2019\u201325.","journal-title":"Lancet"},{"issue":"1","key":"4826_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/emmm.201201973","volume":"5","author":"L Jacquet","year":"2013","unstructured":"Jacquet L, Stephenson E, Collins R, Patel H, Trussler J, Al-Bedaery R, et al. Strategy for the creation of clinical grade hESC line banks that HLA-match a target population. EMBO Mol Med. 2013;5(1):10\u20137.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4826_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13287-023-03612-0","volume":"14","author":"M Alowaysi","year":"2023","unstructured":"Alowaysi M, Lehmann R, Al-Shehri M, Baadhaim M, Alzahrani H, Aboalola D, et al. HLA-based banking of induced pluripotent stem cells in Saudi Arabia. Stem Cell Res Ther. 2023;14(1):374.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"4826_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nbt0708-739","volume":"26","author":"N Nakatsuji","year":"2008","unstructured":"Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol. 2008;26(7):739\u201340.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4826_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5966\/sctm.2014-0110","volume":"4","author":"JA Heslop","year":"2015","unstructured":"Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, et al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med. 2015;4(4):389\u2013400.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"4826_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trre.2016.02.001","volume":"30","author":"SD Sackett","year":"2016","unstructured":"Sackett SD, Brown ME, Tremmel DM, Ellis T, Burlingham WJ, Odorico JS. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. Transplant Rev (Orlando). 2016;30(2):61\u201370.","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"4826_CR34","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1038\/s41467-019-12324-0","volume":"10","author":"R Aron Badin","year":"2019","unstructured":"Aron Badin R, Bugi A, Williams S, Vadori M, Michael M, Jan C, et al. MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates. Nat Commun. 2019;10(1):4357.","journal-title":"Nat Commun"},{"issue":"10","key":"4826_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1182\/blood-2016-09-737825","volume":"129","author":"CG Kanakry","year":"2017","unstructured":"Kanakry CG, Bola\u00f1os-Meade J, Kasamon YL, Zahurak M, Durakovic N, Furlong T, et al. Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide. Blood. 2017;129(10):1389\u201393.","journal-title":"Blood"},{"issue":"4","key":"4826_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell. 2019;24(4):566-578.e567.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"4826_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","volume":"19","author":"R Lanza","year":"2019","unstructured":"Lanza R, Russell DW, Nagy A. Engineering universal cells that evade immune detection. Nat Rev Immunol. 2019;19(12):723\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4826_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3904\/kjim.2016.198","volume":"32","author":"EJ Kim","year":"2017","unstructured":"Kim EJ, Kang KH, Ju JH. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Korean J Intern Med. 2017;32(1):42\u201361.","journal-title":"Korean J Intern Med"},{"issue":"10","key":"4826_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5483\/BMBRep.2021.54.10.094","volume":"54","author":"S Yang","year":"2021","unstructured":"Yang S, Cho Y, Jang J. Single cell heterogeneity in human pluripotent stem cells. BMB Rep. 2021;54(10):505\u201315.","journal-title":"BMB Rep"},{"issue":"17","key":"4826_CR40","first-page":"2085","volume":"141","author":"C Li","year":"2023","unstructured":"Li C, Georgakopoulou A, Newby GA, Chen PJ, Everette KA, Paschoudi K, et al. In vivo HSC prime editing rescues sickle cell disease in a mouse model. Blood. 2023;141(17):2085\u201399.","journal-title":"Blood"},{"issue":"6","key":"4826_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s12015-024-10715-5","volume":"20","author":"C Zhang","year":"2024","unstructured":"Zhang C, Xu J, Wu Y, Xu C, Xu P. Base editors-mediated gene therapy in hematopoietic stem cells for hematologic diseases. Stem Cell Rev Rep. 2024;20(6):1387\u2013405.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4826_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41467-022-35508-7","volume":"14","author":"J Liao","year":"2023","unstructured":"Liao J, Chen S, Hsiao S, Jiang Y, Yang Y, Zhang Y, et al. Therapeutic adenine base editing of human hematopoietic stem cells. Nat Commun. 2023;14(1):207.","journal-title":"Nat Commun"},{"key":"4826_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae207","author":"Z Li","year":"2024","unstructured":"Li Z, Napolitano A, Fedele M, Gao X, Napolitano F. AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data. Brief Bioinform. 2024. https:\/\/doi.org\/10.1093\/bib\/bbae207.","journal-title":"Brief Bioinform"},{"issue":"1","key":"4826_CR44","doi-asserted-by":"publisher","first-page":"21614","DOI":"10.1038\/s41598-022-25423-8","volume":"12","author":"H Kim","year":"2022","unstructured":"Kim H, Park K, Yon JM, Kim SW, Lee SY, Jeong I, et al. Predicting multipotency of human adult stem cells derived from various donors through deep learning. Sci Rep. 2022;12(1):21614.","journal-title":"Sci Rep"},{"issue":"3","key":"4826_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.stem.2022.01.011","volume":"29","author":"FT Merkle","year":"2022","unstructured":"Merkle FT, Ghosh S, Genovese G, Handsaker RE, Kashin S, Meyer D, et al. Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation. Cell Stem Cell. 2022;29(3):472-486.e477.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4826_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s40778-022-00221-0","volume":"8","author":"TB Meissner","year":"2022","unstructured":"Meissner TB, Schulze HS, Dale SM. Immune editing: overcoming immune barriers in stem cell transplantation. Curr Stem Cell Rep. 2022;8(4):206\u201318.","journal-title":"Curr Stem Cell Rep"},{"issue":"3","key":"4826_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.stemcr.2017.07.020","volume":"9","author":"H Ichise","year":"2017","unstructured":"Ichise H, Nagano S, Maeda T, Miyazaki M, Miyazaki Y, Kojima H, et al. NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs. Stem Cell Reports. 2017;9(3):853\u201367.","journal-title":"Stem Cell Reports"},{"issue":"10","key":"4826_CR48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","volume":"4","author":"D Wang","year":"2015","unstructured":"Wang D, Quan Y, Yan Q, Morales JE, Wetsel RA. Targeted disruption of the \u03b22-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Transl Med. 2015;4(10):1234\u201345.","journal-title":"Stem Cells Transl Med"},{"key":"4826_CR49","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol. 2017;8:1124.","journal-title":"Front Immunol"},{"issue":"31","key":"4826_CR50","doi-asserted-by":"publisher","first-page":"12879","DOI":"10.1073\/pnas.0901653106","volume":"106","author":"C Sola","year":"2009","unstructured":"Sola C, Andr\u00e9 P, Lemmers C, Fuseri N, Bonnafous C, Bl\u00e9ry M, et al. Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A. 2009;106(31):12879\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4826_CR51","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3727\/096368910X513991","volume":"19","author":"JE Lee","year":"2010","unstructured":"Lee JE, Kang MS, Park MH, Shim SH, Yoon TK, Chung HM, et al. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes. Cell Transplant. 2010;19(11):1383\u201395.","journal-title":"Cell Transplant"},{"issue":"19-20","key":"4826_CR52","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1089\/ten.tea.2015.0105","volume":"21","author":"Z Karabekian","year":"2015","unstructured":"Karabekian Z, Ding H, Stybayeva G, Ivanova I, Muselimyan N, Haque A, et al. HLA class I depleted hESC as a source of hypoimmunogenic cells for tissue engineering applications. Tissue Eng Part A. 2015;21(19\u201320):2559\u201371.","journal-title":"Tissue Eng Part A"},{"issue":"13","key":"4826_CR53","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1089\/scd.2012.0088","volume":"21","author":"A Zimmermann","year":"2012","unstructured":"Zimmermann A, Preynat-Seauve O, Tiercy JM, Krause KH, Villard J. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev. 2012;21(13):2364\u201373.","journal-title":"Stem Cells Dev"},{"issue":"8","key":"4826_CR54","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki M, Tomberg K, Bradley A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol. 2018;36(8):765\u201371.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4826_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13287-023-03576-1","volume":"14","author":"B Kuebler","year":"2023","unstructured":"Kuebler B, Alvarez-Palomo B, Aran B, Casta\u00f1o J, Rodriguez L, Raya A, et al. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population. Stem Cell Res Ther. 2023;14(1):366.","journal-title":"Stem Cell Res Ther"},{"key":"4826_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-023-01133-y","author":"J Harding","year":"2023","unstructured":"Harding J, Vintersten-Nagy K, Yang H, Tang JK, Shutova M, Jong ED, et al. Immune-privileged tissues formed from immunologically cloaked mouse embryonic stem cells survive long term in allogeneic hosts. Nat Biomed Eng. 2023. https:\/\/doi.org\/10.1038\/s41551-023-01133-y.","journal-title":"Nat Biomed Eng"},{"key":"4826_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812393","volume":"13","author":"L Hensen","year":"2022","unstructured":"Hensen L, Illing PT, Rowntree LC, Davies J, Miller A, Tong SYC, et al. T Cell epitope discovery in the context of distinct and unique indigenous HLA profiles. Front Immunol. 2022;13:812393.","journal-title":"Front Immunol"},{"issue":"1","key":"4826_CR58","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1038\/s41467-023-40220-1","volume":"14","author":"BD Huisman","year":"2023","unstructured":"Huisman BD, Guan N, R\u00fcckert T, Garner L, Singh NK, McMichael AJ, et al. High-throughput characterization of HLA-E-presented CD94\/NKG2x ligands reveals peptides which modulate NK cell activation. Nat Commun. 2023;14(1):4809.","journal-title":"Nat Commun"},{"issue":"11","key":"4826_CR59","volume":"14","author":"AM Joseph","year":"2022","unstructured":"Joseph AM, Karas M, Ramadan Y, Joubran E, Jacobs RJ. Ethical perspectives of therapeutic human genome editing from multiple and diverse viewpoints: a scoping review. Cureus. 2022;14(11):e31927.","journal-title":"Cureus"},{"issue":"3","key":"4826_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jgf2.321","volume":"21","author":"J Rothschild","year":"2020","unstructured":"Rothschild J. Ethical considerations of gene editing and genetic selection. J Gen Fam Med. 2020;21(3):37\u201347.","journal-title":"J Gen Fam Med"},{"issue":"2","key":"4826_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s40778-015-0011-7","volume":"1","author":"J Barry","year":"2015","unstructured":"Barry J, Hyllner J, Stacey G, Taylor CJ, Turner M. Setting up a haplobank: issues and solutions. Curr Stem Cell Rep. 2015;1(2):110\u20137.","journal-title":"Curr Stem Cell Rep"},{"key":"4826_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fimmu.2016.00037","volume":"7","author":"AW Taylor","year":"2016","unstructured":"Taylor AW. Ocular immune privilege and transplantation. Front Immunol. 2016;7:37.","journal-title":"Front Immunol"},{"issue":"3","key":"4826_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nbt1383","volume":"26","author":"K Osafune","year":"2008","unstructured":"Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26(3):313\u20135.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"4826_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.stem.2010.12.008","volume":"8","author":"SJ Kattman","year":"2011","unstructured":"Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, et al. Stage-specific optimization of activin\/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011;8(2):228\u201340.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4826_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101560","volume":"3","author":"DM Lyra-Leite","year":"2022","unstructured":"Lyra-Leite DM, Guti\u00e9rrez-Guti\u00e9rrez \u00d3, Wang M, Zhou Y, Cyganek L, Burridge PW. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protoc. 2022;3(3):101560.","journal-title":"STAR Protoc"},{"key":"4826_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.658088","volume":"9","author":"Y Gao","year":"2021","unstructured":"Gao Y, Pu J. Differentiation and application of human pluripotent stem cells derived cardiovascular cells for treatment of heart diseases: promises and challenges. Front Cell Dev Biol. 2021;9:658088.","journal-title":"Front Cell Dev Biol"},{"key":"4826_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-11096-3_6","volume":"1123","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Ohnuma K, Furue MK. Pluripotent stem cell heterogeneity. Adv Exp Med Biol. 2019;1123:71\u201394.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"4826_CR68","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.chembiol.2019.05.007","volume":"26","author":"A Friese","year":"2019","unstructured":"Friese A, Ursu A, Hochheimer A, Sch\u00f6ler HR, Waldmann H, Bruder JM. The convergence of stem cell technologies and phenotypic drug discovery. Cell Chem Biol. 2019;26(8):1050\u201366.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"4826_CR69","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4826_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-0043-1777072","volume":"10","author":"M Radak","year":"2023","unstructured":"Radak M, Fallahi H. The epigenetic regulation of quiescent in stem cells. Glob Med Genet. 2023;10(4):339\u201344.","journal-title":"Glob Med Genet"},{"issue":"1","key":"4826_CR71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41392-022-01066-z","volume":"7","author":"Y Huang","year":"2022","unstructured":"Huang Y, Bai Z, Zhang K. A new insight for stem cell therapy: apoptotic stem cells as a key player. Signal Transduct Target Ther. 2022;7(1):299.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4826_CR72","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3267","volume":"19","author":"AS Lee","year":"2013","unstructured":"Lee AS, Tang C, Rao MS, Weissman IL, Wu JC. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med. 2013;19(8):998\u20131004.","journal-title":"Nat Med"},{"issue":"1","key":"4826_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1900\/RDS.2014.11.19","volume":"11","author":"J Chmielowiec","year":"2014","unstructured":"Chmielowiec J, Borowiak M. In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors. Rev Diabet Stud. 2014;11(1):19\u201334.","journal-title":"Rev Diabet Stud"},{"issue":"16","key":"4826_CR74","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.4161\/cc.8.16.9353","volume":"8","author":"AS Lee","year":"2009","unstructured":"Lee AS, Tang C, Cao F, Xie X, van der Bogt K, Hwang A, et al. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle. 2009;8(16):2608\u201312.","journal-title":"Cell Cycle"},{"issue":"12","key":"4826_CR75","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/nbt.2051","volume":"29","author":"K Amps","year":"2011","unstructured":"Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29(12):1132\u201344.","journal-title":"Nat Biotechnol"},{"key":"4826_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12958-015-0005-4","volume":"13","author":"N Desai","year":"2015","unstructured":"Desai N, Rambhia P, Gishto A. Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol. 2015;13:9.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"4826_CR77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.gene.2013.07.101","volume":"534","author":"S Malchenko","year":"2014","unstructured":"Malchenko S, Xie J, de Fatima Bonaldo M, Vanin EF, Bhattacharyya BJ, Belmadani A, et al. Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies. Gene. 2014;534(2):400\u20137.","journal-title":"Gene"},{"key":"4826_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00241","volume":"5","author":"LG Eissenberg","year":"2014","unstructured":"Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF. Suicide genes: monitoring cells in patients with a safety switch. Front Pharmacol. 2014;5:241.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4826_CR79","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/sctm.18-0096","volume":"8","author":"K Kojima","year":"2019","unstructured":"Kojima K, Miyoshi H, Nagoshi N, Kohyama J, Itakura G, Kawabata S, et al. Selective ablation of tumorigenic cells following human induced pluripotent stem cell-derived neural stem\/progenitor cell transplantation in spinal cord injury. Stem Cells Transl Med. 2019;8(3):260\u201370.","journal-title":"Stem Cells Transl Med"},{"key":"4826_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00254","volume":"5","author":"BS Jones","year":"2014","unstructured":"Jones BS, Lamb LS, Goldman F, Di Stasi A. Improving the safety of cell therapy products by suicide gene transfer. Front Pharmacol. 2014;5:254.","journal-title":"Front Pharmacol"},{"key":"4826_CR81","first-page":"1","volume":"4","author":"P Zarogoulidis","year":"2013","unstructured":"Zarogoulidis P, Darwiche K, Sakkas A, Yarmus L, Huang H, Li Q, et al. Suicide gene therapy for cancer - current strategies. J Genet Syndr Gene Ther. 2013;4:1.","journal-title":"J Genet Syndr Gene Ther"},{"issue":"4","key":"4826_CR82","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nprot.2017.007","volume":"12","author":"R Hayashi","year":"2017","unstructured":"Hayashi R, Ishikawa Y, Katori R, Sasamoto Y, Taniwaki Y, Takayanagi H, et al. Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells. Nat Protoc. 2017;12(4):683\u201396.","journal-title":"Nat Protoc"},{"issue":"10","key":"4826_CR83","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/cas.13334","volume":"108","author":"HY Lee","year":"2017","unstructured":"Lee HY, Hong IS. Double-edged sword of mesenchymal stem cells: cancer-promoting versus therapeutic potential. Cancer Sci. 2017;108(10):1939\u201346.","journal-title":"Cancer Sci"},{"issue":"1609","key":"4826_CR84","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0334","volume":"368","author":"HT Lin","year":"2013","unstructured":"Lin HT, Otsu M, Nakauchi H. Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond B Biol Sci. 2013;368(1609):20110334.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"4826_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fertnstert.2018.01.005","volume":"109","author":"B Levy","year":"2018","unstructured":"Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril. 2018;109(2):201\u201312.","journal-title":"Fertil Steril"},{"issue":"1","key":"4826_CR86","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12864-023-09158-y","volume":"24","author":"A Maslova","year":"2023","unstructured":"Maslova A, Plotnikov V, Nuriddinov M, Gridina M, Fishman V, Krasikova A. Hi-C analysis of genomic contacts revealed karyotype abnormalities in chicken HD3 cell line. BMC Genomics. 2023;24(1):66.","journal-title":"BMC Genomics"},{"issue":"4","key":"4826_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005932","volume":"12","author":"FJ Rouhani","year":"2016","unstructured":"Rouhani FJ, Nik-Zainal S, Wuster A, Li Y, Conte N, Koike-Yusa H, et al. Mutational history of a human cell lineage from somatic to induced pluripotent stem cells. PLoS Genet. 2016;12(4):e1005932.","journal-title":"PLoS Genet"},{"issue":"7653","key":"4826_CR88","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature22312","volume":"545","author":"FT Merkle","year":"2017","unstructured":"Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545(7653):229\u201333.","journal-title":"Nature"},{"issue":"3","key":"4826_CR89","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/cas.13505","volume":"109","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018;109(3):513\u201322.","journal-title":"Cancer Sci"},{"issue":"11","key":"4826_CR90","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka Z, Bamford S, Cole CG, Ward SA, Dunham I, Forbes SA. The COSMIC cancer gene census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018;18(11):696\u2013705.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4826_CR91","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;376(11):1038\u201346.","journal-title":"N Engl J Med"},{"issue":"1","key":"4826_CR92","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41467-019-13830-x","volume":"11","author":"R Araki","year":"2020","unstructured":"Araki R, Hoki Y, Suga T, Obara C, Sunayama M, Imadome K, et al. Genetic aberrations in iPSCs are introduced by a transient G1\/S cell cycle checkpoint deficiency. Nat Commun. 2020;11(1):197.","journal-title":"Nat Commun"},{"issue":"2","key":"4826_CR93","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/physrev.00054.2003","volume":"85","author":"AM Wobus","year":"2005","unstructured":"Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev. 2005;85(2):635\u201378.","journal-title":"Physiol Rev"},{"issue":"3","key":"4826_CR94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/humrep\/del418","volume":"22","author":"M Geens","year":"2007","unstructured":"Geens M, Van de Velde H, De Block G, Goossens E, Van Steirteghem A, Tournaye H. The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Hum Reprod. 2007;22(3):733\u201342.","journal-title":"Hum Reprod"},{"key":"4826_CR95","first-page":"54641","volume":"117","author":"X Liao","year":"2016","unstructured":"Liao X, Makris M, Luo XM. Fluorescence-activated cell sorting for purification of plasmacytoid dendritic cells from the mouse bone marrow. J Vis Exp. 2016;117:54641.","journal-title":"J Vis Exp"},{"issue":"8a","key":"4826_CR96","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1582-4934.2009.00837.x","volume":"13","author":"A Hmadcha","year":"2009","unstructured":"Hmadcha A, Dom\u00ednguez-Bendala J, Wakeman J, Arredouani M, Soria B. The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med. 2009;13(8a):1464\u201375.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"4826_CR97","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1007\/s12035-021-02324-x","volume":"58","author":"N Fayazi","year":"2021","unstructured":"Fayazi N, Sheykhhasan M, Soleimani Asl S, Najafi R. Stem cell-derived exosomes: a new strategy of neurodegenerative disease treatment. Mol Neurobiol. 2021;58(7):3494\u2013514.","journal-title":"Mol Neurobiol"},{"key":"4826_CR98","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","volume":"10","author":"J Fucikova","year":"2019","unstructured":"Fucikova J, Palova-Jelinkova L, Bartunkova J, Spisek R. Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications. Front Immunol. 2019;10:2393.","journal-title":"Front Immunol"},{"issue":"1","key":"4826_CR99","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/pharmaceutics5010094","volume":"5","author":"B Yao","year":"2013","unstructured":"Yao B, Zhu L, Jiang Q, Xia HA. Safety monitoring in clinical trials. Pharmaceutics. 2013;5(1):94\u2013106.","journal-title":"Pharmaceutics"},{"key":"4826_CR100","unstructured":"(FDA) FaDA: Considerations for the Design of Early - Phase Clinical Trials of Cellular and Gene Therapy Products; Guidance for Industry. In.; 2015."},{"issue":"1","key":"4826_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcyt.2012.10.008","volume":"15","author":"CA Bravery","year":"2013","unstructured":"Bravery CA, Carmen J, Fong T, Oprea W, Hoogendoorn KH, Woda J, et al. Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy. 2013;15(1):9\u201319.","journal-title":"Cytotherapy"},{"issue":"4","key":"4826_CR102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/rme.14.25","volume":"9","author":"J Basu","year":"2014","unstructured":"Basu J, Ludlow JW. Cell-based therapeutic products: potency assay development and application. Regen Med. 2014;9(4):497\u2013512.","journal-title":"Regen Med"},{"key":"4826_CR103","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/bs.ctdb.2020.12.009","volume":"142","author":"D Chowdhury","year":"2021","unstructured":"Chowdhury D, Watters K, Biederer T. Synaptic recognition molecules in development and disease. Curr Top Dev Biol. 2021;142:319\u201370.","journal-title":"Curr Top Dev Biol"},{"issue":"5586","key":"4826_CR104","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1126\/science.1072356","volume":"297","author":"T Biederer","year":"2002","unstructured":"Biederer T, Sara Y, Mozhayeva M, Atasoy D, Liu X, Kavalali ET, et al. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science. 2002;297(5586):1525\u201331.","journal-title":"Science"},{"issue":"2","key":"4826_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00656997","volume":"391","author":"OP Hamill","year":"1981","unstructured":"Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391(2):85\u2013100.","journal-title":"Pflugers Arch"},{"issue":"2","key":"4826_CR106","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0006-3495(78)85489-7","volume":"22","author":"B Hille","year":"1978","unstructured":"Hille B. Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J. 1978;22(2):283\u201394.","journal-title":"Biophys J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04826-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:04:04Z","timestamp":1767060244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04826-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4826"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04826-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not involve studies with human participants or animals conducted by any of the authors. Ethics approval was therefore not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"694"}}